Shares of Owens & Minor, Inc. (NYSE:OMI – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eight brokerages that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $18.50.
Several equities research analysts have recently issued reports on the company. Barclays reduced their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. Robert W. Baird decreased their target price on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. Citigroup cut their price target on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Finally, UBS Group cut their price target on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, November 5th.
Read Our Latest Stock Report on Owens & Minor
Owens & Minor Price Performance
Owens & Minor (NYSE:OMI – Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. During the same period in the prior year, the business posted $0.44 earnings per share. Owens & Minor’s revenue for the quarter was up 5.0% compared to the same quarter last year. Equities research analysts expect that Owens & Minor will post 1.49 EPS for the current fiscal year.
Insider Activity
In related news, CFO Jonathan A. Leon sold 5,282 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the sale, the chief financial officer now owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 2.62% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Owens & Minor
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Deerfield Management Company L.P. Series C increased its position in shares of Owens & Minor by 30.6% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock worth $86,014,000 after purchasing an additional 1,493,852 shares during the last quarter. Foundry Partners LLC acquired a new position in shares of Owens & Minor during the 3rd quarter worth about $5,238,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Owens & Minor by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,028,236 shares of the company’s stock valued at $31,823,000 after purchasing an additional 187,079 shares during the period. Algert Global LLC lifted its stake in Owens & Minor by 189.4% in the 3rd quarter. Algert Global LLC now owns 276,438 shares of the company’s stock valued at $4,337,000 after purchasing an additional 180,922 shares during the last quarter. Finally, Renaissance Technologies LLC grew its holdings in Owens & Minor by 16.5% during the second quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock worth $16,829,000 after purchasing an additional 176,250 shares during the period. 98.04% of the stock is owned by institutional investors and hedge funds.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Featured Stories
- Five stocks we like better than Owens & Minor
- What is a support level?
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Airline Stocks – Top Airline Stocks to Buy Now
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.